Tumor regression and pharmacodynamic (PD) biomarker validation in non-small cell lung cancer (NSCLC) patients treated with the ErbB/VEGFR inhibitor BMS-690514

被引：0
|
作者：
Bahleda, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Soria, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Harbison, C. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Park, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Felip, E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Hanna, N. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Laurie, S. A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Armand, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Shepherd, F. A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Herbst, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Valle Hebron Univ Hosp, Barcelona, Spain
[5] Indiana Univ, Ctr Canc, Indianapolis, IN 46204 USA
[6] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[7] Inst Claudius Regaud, Toulouse, France
[8] Univ Toronto, Toronto, ON, Canada
[9] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8098
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    LUNG CANCER, 2006, 52 : S19 - S19
  • [22] ERBB2 AND ERBB3 EXPRESSION IN RESECTED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS)
    Freixinos, Victor
    Salcedo, Maite
    Tallada, Natalia
    Murtra-Garrell, Nuria
    Navarro, Alejandro
    Martinez, Pablo
    Cedres, Susana
    Teixido, Cristina
    Hernandez-Losa, Javier
    Lopez, Eva
    Montero, M. A.
    Peg, Vicente
    Pallisa, Esther
    Canela, Mercedes
    Felip, Enriqueta
    Ramon Y Cajal, Santiago
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1063 - S1064
  • [23] Khorana Score: A Potential New Biomarker for Real Life Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immunotherapy
    Bjornhart, B.
    Hansen, K.
    Jorgensen, T.
    Herrstedt, J.
    Schytte, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S980 - S981
  • [24] Harmonization radiomics models to predict tumor response in non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    Yadav, Monica
    Lee, Jeeyeon
    Kim, Peter Haseok
    Lee, Seyoung
    Um, Taegyu
    Lee, Salie
    Chuchuca, Maria Jose
    Djunadi, Trie Arni
    Chung, Liam Il-Young
    Yu, Jisang
    Rodrigues, Darren
    Gennaro, Nicolo
    Kim, Leeseul
    Nam, Myungwoo
    Oh, Youjin
    Yoon, Sungmi
    Shah, Zunairah
    Kim, Yuchan
    Hong, Ilene
    Jang, Jessica
    Kang, Grace
    Cho, Amy
    Lee, Soowon
    Hong, Timothy
    Nam, Cecilia
    Velichko, Yury S.
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor
    Ku, Bo Mi
    Kim, Yeon Jeong
    Park, Donghyun
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    Sun, Jong-Mu
    ONCOLOGY, 2022, 100 (04) : 228 - 237
  • [26] Adjuvant Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Preoperative Chemotherapy
    Deng, L.
    Jiang, C.
    Perimbeti, S.
    Chen, H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S234 - S234
  • [27] RISK OF KIDNEY FAILURE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH PEMETREXED
    Kongsted, P.
    Mellemgaard, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 444 - 444
  • [28] Radiomic analysis of non-small cell lung cancer (NSCLC) patients treated with radical radiotherapy
    Hindocha, S.
    Orton, M.
    Doran, S.
    Philipps, L.
    Koh, D-M
    Blackledge, M.
    Lee, R.
    LUNG CANCER, 2020, 139 : S41 - S41
  • [29] PEMETREXED MONOTHERAPY FOR JAPANESE PATIENTS WITH PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC)
    Sato, Akira
    Misumi, Yuki
    Kashizaki, Fumihiro
    Ishii, Mari
    Shimokawa, Tsuneo
    Hida, Naoya
    Okamoto, Hiroaki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1213 - S1214
  • [30] Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
    Shicheng Guo
    Fengyang Yan
    Jibin Xu
    Yang Bao
    Ji Zhu
    Xiaotian Wang
    Junjie Wu
    Yi Li
    Weilin Pu
    Yan Liu
    Zhengwen Jiang
    Yanyun Ma
    Xiaofeng Chen
    Momiao Xiong
    Li Jin
    Jiucun Wang
    Clinical Epigenetics, 2015, 7
12345